Go to deals
Consumer & Retail

Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange

Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange consisting of capital increase and disposal of secondary shares.

Founded in 2013, Pilulka is one of the most significant players consolidating the online and offline pharmacy markets in Central Europe. Pilulka is the number one pharmacy e-shop in the home delivery segment in the Czech Republic and Slovakia, and among the top three retail pharmacy chains in the Czech Republic, with 152 branded pharmacies. The company entered the Romanian online pharmacy market in 2018 and plans to expand to Hungary in 2021. Pilulka is a data-driven market disruptor leveraging its tailor-made and easily scalable IT solutions. Furthermore, the company is backed by a strong management team led by Czech e-commerce tycoons Petr and Martin Kasa, who founded the company.

Oaklins’ team in the Czech Republic acted as IPO manager in this transaction. The team succeeded in attracting orders from high-net-worth individuals and experienced investors, and also from a broad range of retail and institutional investors.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Miloš  Čebík

Miloš Čebík

Director
Prague, Czech Republic
Oaklins WOOD & Co.
 Robin  Ibl

Robin Ibl

Senior Associate
Prague, Czech Republic
Oaklins WOOD & Co.

Related deals

Change Financial (ASX:CCA) has raised US$4 million
Financial Services

Change Financial (ASX:CCA) has raised US$4 million

Change Financial has completed a capital raise to help accelerate product enhancement, repay its debt, provide working capital and cover the costs of the offer.

Learn more
Dan Deal has been acquired by Shufersal
Consumer & Retail

Dan Deal has been acquired by Shufersal

The owners of Dan Deal have sold the company to Shufersal.

Learn more
Jessy Diffusion has been acquired by Transmed
Consumer & Retail | Food & Beverage

Jessy Diffusion has been acquired by Transmed

The Nahmias Family has sold Jessy Diffusion to Transmed.

Learn more